148 related articles for article (PubMed ID: 20734236)
1. Thymoma associated with malignancies may herald a hereditary cancer syndrome.
Tehrani OS; Chen EQ; Schaebler DL; Mughal AW
Fam Cancer; 2010 Dec; 9(4):655-7. PubMed ID: 20734236
[TBL] [Abstract][Full Text] [Related]
2. ATM mutation in a patient with thymoma-associated myasthenia gravis.
Yuen C; Soliven B; Rezania K
Muscle Nerve; 2020 Aug; 62(2):E50-E52. PubMed ID: 32445285
[No Abstract] [Full Text] [Related]
3. TP53 and EGFR Mutational Status in Thymoma: A Genetic Sequencing Study.
Syahruddin E; Zaini J; Sembiring R; Baginta R; Fadhillah MR; Noor DR
Asian Pac J Cancer Prev; 2022 Jan; 23(1):109-114. PubMed ID: 35092378
[TBL] [Abstract][Full Text] [Related]
4. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3.
Sakane T; Murase T; Okuda K; Saida K; Masaki A; Yamada T; Saito Y; Nakanishi R; Inagaki H
Histopathology; 2019 Nov; 75(5):755-766. PubMed ID: 31179560
[TBL] [Abstract][Full Text] [Related]
5. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
6. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
[TBL] [Abstract][Full Text] [Related]
7. Thymoma: diagnostic and therapeutic aspects.
Skor RB; Jaeschke WH; Vermund H
Wis Med J; 1968 Aug; 67(8):361-73. PubMed ID: 5670982
[No Abstract] [Full Text] [Related]
8. Current approaches to the treatment of thymoma.
Loehrer PJ
Ann Med; 1999 Oct; 31 Suppl 2():73-9. PubMed ID: 10574160
[TBL] [Abstract][Full Text] [Related]
9. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
10. Recurrent TP53 missense mutation in cancer patients of Arab descent.
Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
[TBL] [Abstract][Full Text] [Related]
11. Does familial breast cancer and thymoma suggest a cancer syndrome? A family perspective.
Zhang X; Wang T; Wang W; Ding Y; Zhou L; Chen Q; Gao X; Wu Y; Mei Y; Jin Y; Gao Q; Yi L
Gene; 2015 Dec; 573(2):333-7. PubMed ID: 26344711
[TBL] [Abstract][Full Text] [Related]
12. [Familial thymoma].
Wuketich S; Zwintz E
Wien Klin Wochenschr; 1983 Jun; 95(12):424-8. PubMed ID: 6613140
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy in thymoma and associated multiple primary malignancies in the same patient.
Sitić S; Mirt-Dabić M; Brcić L; Juros Z; Hutinec Z; Kruslin B
Acta Clin Croat; 2008 Sep; 47(3):155-9. PubMed ID: 19175064
[TBL] [Abstract][Full Text] [Related]
14. [Familial thymoma and translocation t (14;20) (q24;p13)].
Deminatti MM; Ribet M; Gosselin B; Bauters F; Mencier E; Savary JB; Lai JL; Vasseur F; Morel P; Bisiau-Leconte S
Ann Genet; 1994; 37(2):72-4. PubMed ID: 7985981
[TBL] [Abstract][Full Text] [Related]
15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
16. [Advance in diagnosis and management for thymoma].
Wang JH; Zhang SC
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):717-9. PubMed ID: 16255960
[No Abstract] [Full Text] [Related]
17. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.
Wu CC; Krahe R; Lozano G; Zhang B; Wilson CD; Jo EJ; Amos CI; Shete S; Strong LC
Hum Genet; 2011 Jun; 129(6):663-73. PubMed ID: 21305319
[TBL] [Abstract][Full Text] [Related]
19. Thymoma and thymic carcinoma in the target therapies era.
Lamarca A; Moreno V; Feliu J
Cancer Treat Rev; 2013 Aug; 39(5):413-20. PubMed ID: 23261165
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
